The Supreme Court Is Paying Attention To Patent Law Again
Law360, New York (April 1, 2013, 11:54 AM EDT) -- The U.S. Supreme Court's decision in Mayo v. Prometheus surprised many patent practitioners with both its reasoning and its expected impact in a fast developing industry. Yet, a close look at Justice Stephen Breyer's dissent from the denial of certiorari in Lab. Corp. in 2006 renders that surprise curious. Indeed, Justice Breyer had put the legal field on notice that the Supreme Court was paying attention to patent eligibility well before seemingly eliminating medical diagnostic patents with Prometheus. With Myriad V to be heard this term, the Supreme Court may further impact the future of patents supporting this field, as it addresses the patentability of isolated DNA sequences....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.